1888 PressRelease Home	Sign In	Register	About Us	Sitemap

1888 Press Release | Gtcbio Press Releases

Gtcbio.com - Gtcbio Company News Section

Gtcbio Information

Rania Hafez

Phone: 626) 256-6405
URL: http://www.gtcbio.com

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com

Gtcbio Press Release -

Gtcbio.com

28 OCT	Joost Oppenheim MD, Lab Chief - NCI, to give Keynote at the 8th Cytokines & Inflammation Conference
	Joost Oppenheim, Laboratory Chief at the Laboratory of Molecular Immunoregulation - NCI Frederick, is to give a keynote presentation on a group of structurally diverse multifunctional host proteins called "alarmins", at GTCbio's 8th Cytokines & inflammation Conference on January 28-29, 2010 in San Diego, CA.

07 OCT	Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
	The 7th Annual Vaccines: “All Things Considered” conference is to be held this year in Washington, D.C. on Nov 9-10, 2009 by GTCbio. This conference promises to be the one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy.

26
SEP

Stan Yakatan, CEO of Katan Associates, to do Keynote at the Antibody Partnering & Technology Summit

Stan Yakatan, the Chairman and Chief Executive Officer at Katan Associates, is to give a keynote presentation on the recent approval of a follow-on version of Pfizer’s Genotropin (recombinant human growth hormone), and the beginning of the end of an era where biopharmaceuticals enjoyed immunity from competition even after expiration of their patent protection at GTCbio’s Antibody Partnering & Tech.

27 AUG	Allen Roses, Director Deane Drug Discovery Institute, Keynote At Drug Discovery & Development Summit
	Allen Rose, Director of The Deane Drug Discovery Institute – Duke University, is to give a keynote presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA.

30 JUL	Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
	Amy Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, is to give a keynote presentation concerning regulatory considerations & challenges for immunotherapeutic/diagnostic co-development at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA.

08 JUL	2nd Annual Biomarker Discovery Europe conference to be held on October 1-2, 2009 in Lisbon Portugal
	The conference is in session from October 1-2, 2009 in Lisbon, Portugal with topics ranging from how to decrease the cost of drug discovery to translational research.

03 JUN	Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit
	GTCbio on October 14-16, 2009 in San Diego, CA for professionals or academics interested in Biological Therapeutics.

13 APR	Pete Adamson, Head Of Research At GlaxoSmithKline To Give Keynote At Ocular Diseases Conference
	Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio’s Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.

17 MAR	Joseph Bolen, CSO, Millennium to give Keynote Talk at GTCbio’s 4th Protein Kinase Conference
	Dr. Joseph Bolen, Chief Scientific Officer of Millennium Pharmaceuticals, Inc. will be the keynote speaker at GTCbio’s 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, Massachusetts.

15 MAR	Alison Goss Eng of US Dept. of Energy to Present at GTCbio’s Inaugural Biofuels Conference on June 29-30, 2009
	Alison Goss Eng, from the United States Department of Energy will be the featured speaker at GTCbio’s Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 28-30, 2009 in San Francisco, California.

19 FEB	GTCbio Announces Its Inaugural Ocular Diseases & Drug Discovery Conference
	Due to the unmet needs of ocular disease drug therapies and the growing population of aging individuals, GTCbio is proud to announce its inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.

24 JAN	Susan Richards, PhD, Group VP Of Clinical Laboratory Sciences At Genzyme To Give Keynote Presentation At GTCbio’s 3rd Immunodiagnostics & Immunomonitoring Conference
	Dr. Susan Richards, Group VP of Clinical Laboratory Sciences at Genzyme is scheduled to give the keynote presentation at GTCbio’s 3rd annual Immunodiagnostics & Immunomonitoring Conference.

01 JAN	Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio’s 4th Imaging in Preclinical & Clinical Drug Development Conference
	Charles Peterfy, Chief Scientific Officer at Synarc will give the featured presentation at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA.

21 NOV	GTCbio Announces Its 7th Annual Cytokines & Inflammation Conference
	GTCbio just announced its 7th Annual Conference on Cytokines & Inflammation scheduled for January 29-30, 2009 in Sunny San Diego, California.

21 NOV	Michael Karin, Professor At UCSD To Give Keynote Speech At 7th Cytokines & Inflammation Conference
	Michael Karin, Professor of Pharmacology Tumor Growth Invasion & Metastasis at UCSD to Give Keynote Speech at GTCbio’s 7th Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA.

20 NOV	GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference
	GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida

20 NOV	Samir Hanash, Program Head At The Fred Hutchinson Cancer Research Center To Give Keynote Speech At GTCbio’s 2nd Oncology Biomarkers Conference
	Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference.

06 NOV	GTCBIO Announces Its Inaugural CNS Diseases Partnering & Deal-Making Summit
	GTCbio announced its Inaugural CNS Partnering & Deal-Making Summit being held on December 1-2, 2008 in Boston, MA

06 NOV	Joint Featured Presentation By Eisai & Schering Plough To Be Given At CNS Diseases Partnering And Deal-making Summit
	Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough will give the joint featured address entitled “CNS Deal Outlook: What We Can Learn From Recent Trends” at this year’s CNS Diseases Partnering forum.

21 AUG	Rita Helfand, Associate Director at the Centers for Disease Control and Prevention (CDC) to Give Featured Presentation at GTCbio’s Bugs & Drugs Conference on September 22-23, 2008
	Dr. Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention will speak on “Controlling Infectious Diseases: Progress and Challenges in Addressing Known and Unknown Threats” at GTCbio’s Bugs & Drug Conference on Sept. 22-23, 2008 in San Diego, CA.

21 AUG	Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases, Stanford University to Give Featured Presentation at GTCbio’s Bugs & Drugs Conference on Sept. 22-23, 2008 in San Diego, CA
	Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo Alto, CA will speak on “The Seemingly Never-ending Promise of Bacteriophage Therapy: Exploiting Smaller Fleas” at GTCbio’s Bugs & Drug Conf. on Sept. 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA.

20 AUG	Barry Eisenstein, SVP At Cubist Pharmaceuticals To Give Keynote Presentation At GTCbio’s Bugs & Drugs Conference On September 22-23, 2008 In San Diego, CA
	Dr. Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubist Pharmaceuticals in Lexington, MA and Clinical Professor of Medicine, Harvard Medical School in Cambridge, MA give the keynote address on getting congress to understand the need for antibiotic development.

20 AUG	Sharath Hegde, Vice President At Theravance To Give Featured Presentation At GTCbio’s Bugs & Drugs Conference on September 22-23, 2008 In San Diego, CA
	sharath hegde, vice president of pharmacology at theravance, inc. in south san francisco, ca will speak on “telavancin: a novel lipoglycopeptide gram-positive antibiotic” at gtcbio’s bugs & drug conference on september 22-23, 2008 at the doubletree club hotel in san diego, ca.

09 AUG	GTCbio Announces Its Annual Conference Global Clinical Trial Operations On September 25-26, 2008, San Diego, CA
	GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA.

08 AUG	Gtcbio Announces Its Inaugural Bugs & Dugs Conference On September 22-23, 2008, San Diego, CA
	August 7, 2008 - MONROVIA, CA – GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA.

08 AUG	Gtcbio Announces Its 4th Annual Neurodegenerative Diseases Drug Discovery Conference On October 9-10, 2008 In Philadelphia, PA
	GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA.

08 AUG	GTCbio Announces Its Biomarker Discovery Europe Conference On October 2-3, 2008 In Dublin, Ireland
	GTCbio just announced the 3rd edition of its Biomarker Series – the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland.

08 AUG	VP Of Alliance Management & Portfolio Planning At Genentech To Give Plenary Keynote Address At 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 – San Diego, CA)
	Dr. Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech in San Francisco, CA will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 in La Jolla, CA.

02 JUL	Peter Mayne, OSI Pharmaceuticals Presenting At GTCbio’s Global Clinical Trial Operations Conference
	Peter Mayne from OSI Pharmaceuticals presenting on being an EU Qualified Person (QP) as a small offshoot of a virtual company at GTCbio’s Global Clinical Trial Operations conference.

01 JUL	Larry A Blankstein From Genzyme Will Present At GTCbio’s Global Clinical Trial Operations Conference
	Larry A. Blankstein from Genzyme giving a presentation entitled “An Interactive Lessons Learned Process to Optimize Sponsor and Provider Performance on Global Trials” at GTCbio’s Global Clinical Trial Operations Conference.

01 JUL	Mark Lanfear From Roche To Speak At GTCbio’s Global Clinical Trial Operations Conference
	Mark Lanfear, Regional Manager of Kforce-Roche Strategic Alliance at Roche to present on outsourcing clinical trials in emerging regions at GTCbio’s Global Clinical Trial Operations Conference.

01 JUL	Michele Pontinen From Capgemini LLC To Speak At GTCbio’s Global Clinical Trial Operations Conference
	Michele Pontinen from Capgemini to present “Forget About the Boulders – I’m Interested in Mining for the Diamonds!” Data Mining Made Possible by Clinical IT - a Real Life Industrialized Model at GTCbio’s Global Clinical Trial Operations Conference.

29 JUN	Brahm Goldstein Of Novo Nordisk To Speak At GTCbio’s Global Clinical Trial Operations Conference
	Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26

28 JUN	Didier Basseras From Sanofi Aventis To Speak GTCbio’s Global Clinical Trial Operations Conference
	Didier Basseras from Sanofi Aventis giving a presentation entitled “Clinical Packaging and Labelling: Is There Room to Innovate?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA.

27 JUN	Cosimo Spera From Decision View Co. Speaking At GTCbio’s Global Clinical Trial Operations Conference
	Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference

27 JUN	Franco Pasquale From Genentech Presenting At GTCbio’s Global Clinical Trial Operations Conference
	Franco Pasquale, Sr Manager of Manufacturing Collaborations at Genentech to present on devising an international clinical trial distribution strategy using Genentech’s approach at GTCbio’s Global Clinical Trial Operations Conference

27 JUN	Gavin Choy From Supergen Presenting At GTCbio’s Global Clinical Trial Operations Conference
	Gavin Choy, VP of Clinical Research Operations at SuperGen, Inc. giving a presentation entitled ADME in Phase 1 Clinical Trials at GTCbio’s Global Clinical Trial Operations Conference on September 25-26, 2008 in San Diego.

26 JUN	Helen Niu From Amgen Presenting At GTCbio’s Global Clinical Trial Operations Conference
	Dr. Helen Niu, Director of Global Development Operations at Amgen presenting on development strategies for bio-pharmaceuticals in emerging Asian countries at GTCbio’s Global Clinical Trial Operations Conference on Sept 25-26 in San Diego.

26 JUN	Kathleen Drennan From Iris Trials To Present At GTCbio’s Global Clinical Trial Operations Conference
	Kathleen Drennan from Iris Global Clinical Trial Solutions giving a presentation entitled “Clinical Trials In Kids; A Special Population Requiring A Unique Approach” at GTCbio’s Global Clinical Trial Operations Conference on Sept 25-26 in San Diego.

17 JUN	Amrit Ray, VP At BMS To Present At Global Clinical Trial Operations Conf. On Sept 25-26 In San Diego
	Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety.”

15 JUN	VP Of Drug Discovery At Phylogica To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA.

14 JUN	Lino Gonzalez Of Genentech To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA

14 JUN	Group Leader Of Experimental Therapeutics At Celgene To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA.

13 JUN	Ludmilla Morazova-Roche At Umea University In Sweden To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Ludmilla Morazova-Roche at Umeå University in Sweden to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA.

13 JUN	CTO & VP Of Research At Baxter Healthcare To Present At Gtcbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Larry Brown, Chief Technology Officer & VP of Research at Baxter Healthcare to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA.

12 JUN	Director Of Research At BN ImmunoTherapeutics Will Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Alain Delcayre, Director of Research at BN ImmunoTherapeutics will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA

12 JUN	Ingrid Cruzado-Park From Beckman Coulter, Inc To Present At GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference
	Ingrid Cruzado-Park from Beckman Coulter, Inc to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development conference on September 8-9, 2008 in San Diego, CA.

11 JUN	Site Head Of Pfizer La Jolla To Give Plenary Keynote Address At 4th Modern Drug Discovery & Development Summit
	SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 – San Diego, CA).

22 APR	Chip Allee To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference
	Dr. Allee will speak on the issue of special data management considerations for kinetics assays.

22 APR	Can Ozbal To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference
	Dr. Ozbal will be speaking on label-free HTS of intractable targets with rapid-fire mass spectrometry.

21 APR	Gary Piazzo, Program Director Of The Southern Research Molecular Libraries Screening Center To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference
	Dr. Gary Piazzo, Program Director of the Southern Research Molecular Libraries Screening Center at Southern Research Institute will be giving a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Piazzo will be speak on “HTS to Identify MRP1 Inhibitors for Reversal of Multidrug Resistance.”

21 APR	Associate Director At Medimmune To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
	Robert Lechleider, Associate Director at MedImmune to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

20 APR	Gloria Meng, Senior Scientist Of Technology At Genentech To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference On June 5-6, 2008 In San Francisco, CA
	MONROVIA, CA – Dr. Y. Gloria Meng, Senior Scientist of Technology at Genentech will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Meng will speak on electrochemiluminescence to detect surface proteins on live cells.

20 APR	Senior Research Scientist, Intrinsic Bioprobes To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
	Urban Kiernan, Senior Research Scientist, Intrinsic Bioprobes to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

20 APR	Tim Harris Of Saic-frederick To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
	Tim Harris, Director of Advanced Technology Program and Corporate VP of Technology at SAIC-Frederick to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

20 APR	Senior Director Of Technology Management At Roche To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
	Thomas Li, Senior Director of Technology Management at Roche to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

19 APR	Walter Carney To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
	Walter Carney, Head of Oncogene Sciences at Siemens to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

19 APR	Victor Levenson Of Northwestern University To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
	Victor Levenson, Director and Research Associate Professor, Robert H. Lurie Comprehensive Cancer Center at Northwestern University to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA

19 APR	Saju Nettikadan To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
	Saju Nettikadan, Director of Emerging Technologies at BioForce Nanosciences to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA.

17 APR	Matthew Olson To Speak At GTCbio’s 3rd Assay Development & Screening Technologies Conference On June 5-6
	Matthew Olson Principle Research Scientist at Johnson & Johnson to Speak at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA

17 APR	Yudong He, Scientific Director, Rosetta Inpharmatics To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, Ma
	Dr. Yudong He, Scientific Director, Rosetta Inpharmatics will be presenting at GTCbio’s 2nd Annual Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. Dr. Hanash will speak on “Biomarker Discovery: Lessons Learned.”

09 APR	Chris Austin To Give Keynote Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
	Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA

03 APR	Hakim Djaballah, Director Of Hts At Memorial Sloan Kettering Cancer Center To Present At Gtcbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA
	Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications of high content assays using confocal microscopy.

03 APR	John Cuozzo, Director Of ELT Lead Discovery At Glaxosmithkline To Present At GTCbio's 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA
	Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Cuozzo will speak on selecting hits from billions of compounds from encoded library technology.

03 APR	Xi Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
	Xi Chen, Assistant Professor at University of California, Davis to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA

03 APR	Taosheng Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
	Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA

03 APR	Clay Scott Of Astrazeneca To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
	Clay Scott, Associate Director of Lead Generation at AstraZeneca to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA

29 MAR	Dr. Susan Taylor, Professor Of Pharmacology At UCSD To Give Featured Presentation At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6
	Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA.

29 MAR	Dr. Karim Dabbagh, Director Of Pharmacology At Roche To Present At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6
	Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA.

27 MAR	Samuel H. Wood, CEO At Stemagen Will Give A Featured Presentation At The 4th International Stem Cell Research & Therapeutics
	Samuel H. Wood, CEO at Stemagen, which announced on January 17, 2008 that it has become the first in the world to create, and meticulously document, a cloned human embryo using somatic cell nuclear transfer (SCNT), will give a featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	Pfizer To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
	Mark Thiede of Pfizer will give a presentation entitled “Inference by Interference: Controlling MSC Differentiation with RNAi” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	Jan Paul Medema, Professor Of Experimental Oncology And Radiobiology At The University Of Amsterdam To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics
	Jan Paul Medema, Professor of Experimental Oncology and Radiobiology at the Academic Medical Center of the University of Amsterdam, will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	Senior Vice President Of Regenerative Medicine At Geron To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17- 18, 2008 In Boston, MA
	Jane S. Lebkowski, Senior Vice President of Regenerative Medicine at Geron will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	President & Chief Executive Officer Of Sangamo Biosciences To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
	Edward Lanphier, President & Chief Executive Officer at Sangamo BioSciences, which published a new study last October indicating that its technology could be used to modify the genomes in stem cells, create stem cell lines that mimic disease, and modify stem cells to treat diseases, will present at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	Senior Director At Genzyme To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
	Bruce Wentworth, Senior Director of Cardiovascular Research at Genzyme will give a presentation entitled “Retention of Cells after Transplantation” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

27 MAR	Malcolm Moos, Medical Officer Of Division Of Cellular And Gene Therapies At FDA To Give Featured Presentation At The 4th International Stem Cell Research & Therapeutics
	Malcolm Moos, Medical Officer of the Division of Cellular and Gene Therapies at the Food and Drug Administration (FDA) will give the featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA.

26 MAR	GTCbio Announces Its 4th Modern Drug Discovery And Development Summit Taking Place On October 15-17, 2008 In San Diego, CA
	GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA.

26 MAR	Robert Hertzberg, Vice President Of Screening & Compound Profiling At GlaxoSmithKline To Give Keynote Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 200
	Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.”

26 MAR	Jeremy Caldwell To Give The Featured Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA
	Dr. Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation will give the Featured Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Caldwell will discuss broad functional profiling of molecular libraries against biological space.

26 MAR	Berta Strulovici, Vice President Of Basic Research MRL, And Automated Biotechnology Head At Merck & Co. To Give Keynote At GTCbio’s 3rd Assay Development & Screening Technologies Conference
	Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA.

08 MAR	Massachusetts Senator Richard T. Moore To Give Keynote Presentation At GTCbio’s 4th International Conference On Stem Cell Research & Therapeutics On April 17-18, 2008 In Boston, MA
	Senator Richard Moore will speak on April 18, 2008 on recent stem cell legislation and policy initiatives at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics in Boston, MA.

08 JAN	University Of Massachusetts To Present At GTCbio’s 6th Cytokines And Inflammation (January 28-29, 2008, Orlando, Florida)
	Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.)

08 JAN	Director, Molecular Imaging At GSK To Speak At 3rd Imaging In Drug Development Conference March 2008
	Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.

08 JAN	Joint Presentation From Novartis And Human Genome Sciences At Gtcbio’s 5th Anti-infectives Partnering & Deal-making Summit (march 5- 7, 2008, Philadelphia, Pa)
	Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7 2008 in Philadelphia, PA.

08 JAN	Genentech To Present At Gtcbio’s 6th Cytokines And Inflammation (january 28-29, 2008, Orlando, Florida)
	Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.)

08 JAN	Chief, Diagnostic Radiology At Nih To Speak At 3rd Imaging In Drug Development Conference March 2008
	MONROVIA, CA – Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.

08 JAN	Biogen-Idec To Present At GTCbio’s 6th Cytokines And Inflammation (January 28-29, 2008, Orlando, Florida)
	Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.

20 DEC	Joost J. Oppenheim, Chief Of The Laboratory Of Molecular Immunoregulation At NCI, NIH To Present On Regulation Of T Regulatory Cells, January 28, 2008
	Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL.

20 DEC	Big Pharmas To Present At GTCbio’s 3rd Imaging In Drug Development Conference In March 2008
	Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego.

10 NOV	Kenna Anderes Of Pfizer, Michael Shi Of Novartis And Joseph Paul Eder Of Astrazeneca To Give Featured Presentations At Oncology Biomarkers: From Discovery To Validation Conference January 2008
	Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.

10 NOV	Robert Copeland, Vp, Oncology Drug Discovery, Gsk To Give Keynote Talk At Cancer Drugs Conference
	Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix

18 OCT	Dr. David Kaslow, Vice President Of Infectious Diseases And Vaccines At Merck To Give Keynote Presentation At 3rd Modern Drug Discovery & Development Summit
	Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport.

18 OCT	Dr. Stephen K. Burley, CSO And SVP Of Research At SGX Pharmaceuticals Will Give The Keynote Presentation At 3rd Modern Drug Discovery & Development Summit
	Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco.

15 OCT	GTCbio’s 5th International Conference On Vaccines: All Things Considered
	GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C

15 OCT	Metabolic Disease Has A Greater Effect On The Health Of Our Society Than Cancer
	The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases

10 OCT	Gtcbio’s 3rd Modern Drug Discovery And Development Summit
	GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston.

09 OCT	SVP And Site Head Of Pfizer La Jolla To Give Plenary Keynote Address At 3rd Modern Drug Discovery & Development Summit
	SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).